Tele: 561.316.3330
Breaking Medical Device News

Monday, September 20, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeQuest Products LLC.Quest Products LLC Launches a Nasal Filter Device that Blocks Microscopic Airborne Particles and Pollutants

Quest Products LLC Launches a Nasal Filter Device that Blocks Microscopic Airborne Particles and Pollutants

Quest Products, LLC introduces a new nasal filter designed for people interested in protection against the smallest of airborne particles and pollutants. Its unique filtration material is electrostatically charged to better capture microscopic particles and protect people from droplets released during coughing and sneezing. In a study by LMS Technologies, the new breatheWELL Nasal Filter was proven as a unique barrier against airborne particles measuring as small as 3 microns. In fact, the study demonstrated a 90 percent effectiveness against particles measuring 10 microns and 60 percent effectiveness against particles measuring 2.5 microns—this is within the micron measurement range of the smallest sized bacteria, pollen and allergen. According to the results of the study, the nasal filters can block up to 99% of airborne particles and pollutants.

“In recent news reports, immunology and allergy specialists encourage people to do all they can to alleviate inflammation to the lungs caused by breathing in common allergens because it may leave them more susceptible to respiratory illnesses,” said Jon Romanow, Director of Marketing, Quest Products, LLC. “We believe that our new product will be helpful to people seeking additional options to protect their overall health by blocking the inhalation of pollens, pollutants and bacteria that reach the lungs through the nose. These filters are ideal for protection during travel when around pets or while working in dusty environments.”

The unique filtration material makes breatheWELL™ a reliable option for reducing direct and indirect airborne transmission of unwanted particles breatheWELL™ nasal filters fit discreetly into the front of the nostrils. It is drug-free, latex-free and the rings are made of a surgical-grade polymer that is non-toxic.

breatheWELL™ is available now for purchase online at Amazon and at breatheandsleepwell.com.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

Jonathan Chapman: New President/CEO of Trividia Health

Chapman said, “I’m honored to join the Trividia team as President and CEO. This organization has a long history of leadership within the healthcare industry as a provider of accurate, accessible, and affordable point-of-care solutions for the management of diabetes.”

SOLOPASS® System (Bedside Neuro-Navigation Device) Receives FDA 510(k) Clearance

inTRAvent’s SOLOPASS® system brings simple, portable, bedside neuro-navigation into the intensive care unit.

By using this website you agree to accept Medical Device News Magazine Privacy Policy